About Us
Our Vision & Mission
At EAZE BIO, our mission is to empower women through innovative, personalized healthcare solutions that improve reproductive health and support aging. Our goal is to redefine women's health by making personalized medicine the standard for reproductive health and aging. We imagine a world where every woman can access advanced, on-the-spot diagnostics that lead to timely, effective treatments.
Through our research and innovation, we aim to promote a holistic approach that celebrates women's health, ensuring that they feel informed, empowered, and cared for throughout their life journey. Our focus is on providing accessible, rapid diagnostics and promoting informed decision-making, ultimately improving health outcomes and quality of life for women everywhere.
Our Expertise
With a team of experienced medical research professionals, EAZE BIO specializes in translating scientific breakthroughs into practical applications. Our expertise spans various therapeutic areas, ensuring that we meet the diverse needs of the healthcare industry, especially for women.
Research Initiatives
At EAZE BIO, we are dedicated to engaging in diverse research initiatives focusing on critical areas such as point-of-care diagnostic tools and therapeutics. Our goal is to make a significant contribution to the scientific community and to develop therapies that improve the quality of life for patients worldwide.
Our Team
Reem Mahrat - Founder/CEO
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
Janelle Muranaka - Co-Founder/COO
• 23+ years in biopharma industry
• Successful exits scaling impactful ventures
- Raman ID acquired by NOMADX Holdings, 2024
- Calico Biolabs acquired by Abcam, 2019
• Experienced founder at 4 prior companies
• Healthcare innovator delivering transformative point-of-care and diagnostic solutions
Janelle Muranaka - Co-Founder/COO
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
Janelle Muranaka - Co-Founder/COO
• 16+ years in biotech industry
• Proven record scaling biotech startups from seed funding through clinical development
• Employee #2-3 at three prior biotech startups
• Co-founder of Maxygen LLC
• Expertise in cell & molecular biology, vaccine development, and protein engineering
Aditi Malu, Ph.D. - Co-Founder/CSO
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
• 15 years in biological research
• Leads innovation and research at EazeBio
• Translational biology expert generating technical strategies and R&D development plans
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
Ying Chen, Ph.D., MBA candidate - Co-Founder/CTO
• 12+ years in biotech & academic settings
• Published 10+ peer-reviewed articles
• Overseen 1000s of CRISPR gene-editing projects
• Expertise in global cross-team leadership and strategic problem solving
• Medical educator
Bill Howell, M.D., Ph.D. - CMO
Bill Howell, M.D., Ph.D. - CMO
Bill Howell, M.D., Ph.D. - CMO
• Physician-scientist trained in anatomic, clinical, and molecular genetic pathology at Stanford University
• CMO at RamanID, successful exit in 2024
• CMO roles at Tackle Bio (current) and TheraSentient BioPharma (previous)
Meryem Rqibate, M.D., MBA
Bill Howell, M.D., Ph.D. - CMO
Bill Howell, M.D., Ph.D. - CMO
• Conducted clinical research for C-section risk on scarred uterine tissue
• Certificates in Medical Statistics & Python Programming to navigate the intersection of medicine, data science, & biotech innovation
• Director of Operations at Daybreak Labs
Akshiv Malhotra, M.D.
Bill Howell, M.D., Ph.D. - CMO
Akshiv Malhotra, M.D.
• Board-certified medical oncologist at UCSF Health
• Expertise in gastrointestinal cancers, including pancreatic, colorectal, gastric, and esophageal cancers
• Focus on patient care, disease prevention, and healthcare accessibility
Wira Soedarmono, MBA
Vinod Reddy Lekkala, Ph.D.
Akshiv Malhotra, M.D.
• 25+ years of hardware & software development, including AR/ML/AI in multi-industries
• 8+ years of corporate operations, design & manufacturing hardware, & software development
• 3 startups with 1 M&A exit
Vinod Reddy Lekkala, Ph.D.
Vinod Reddy Lekkala, Ph.D.
Vinod Reddy Lekkala, Ph.D.
• Advanced degrees in biotechnology and stem cells for tissue regeneration
• Technical expertise in organoid development, stem cell biology, CRISPR, and cell engineering technologies
Postdoctoral Researcher at UCSF
Dr. Bassam El Fahmawi
Vinod Reddy Lekkala, Ph.D.
Vinod Reddy Lekkala, Ph.D.
• Invented iSWAB for swab-based collection, and HemaSure-OMICs, a direct draw-tube for whole blood multi-omics analysis.
• Founder and CTO of Mawi DNA Technologies, a growth-stage company working at the front lines of the COVID-19 battle.
• More than 25 years of experience in the genomics sample preparation market.
• Led nucleic ac
• Invented iSWAB for swab-based collection, and HemaSure-OMICs, a direct draw-tube for whole blood multi-omics analysis.
• Founder and CTO of Mawi DNA Technologies, a growth-stage company working at the front lines of the COVID-19 battle.
• More than 25 years of experience in the genomics sample preparation market.
• Led nucleic acid purification technologies commercialization at both Beckman Coulter Genomics (formerly Agencourt) and Corning.
• Published several patents for simplifying nucleic acid purification and sample collection.